X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
siltuximab (95) 95
index medicus (89) 89
humans (71) 71
interleukin-6 (51) 51
oncology (47) 47
anti-interleukin-6 monoclonal-antibody (37) 37
cancer (33) 33
hematology (32) 32
siltuximab cnto 328 (32) 32
monoclonal antibodies (29) 29
multiple myeloma (28) 28
female (26) 26
il-6 (26) 26
male (26) 26
animals (25) 25
antibodies, monoclonal - therapeutic use (23) 23
middle aged (22) 22
cytokines (21) 21
double-blind (21) 21
monoclonal-antibody (21) 21
rituximab (21) 21
aged (20) 20
immunology (20) 20
interleukin-6 - antagonists & inhibitors (20) 20
interleukins (20) 20
care and treatment (19) 19
tocilizumab (19) 19
immunotherapy (18) 18
inflammation (18) 18
multiple-myeloma (17) 17
pharmacology & pharmacy (17) 17
adult (16) 16
antineoplastic agents - therapeutic use (16) 16
chemotherapy (16) 16
interleukin-6 - immunology (16) 16
interleukin-6 - metabolism (16) 16
siltuximab anti-il-6 (16) 16
health aspects (14) 14
antibodies, monoclonal - administration & dosage (13) 13
antibodies, monoclonal - adverse effects (13) 13
castleman disease - drug therapy (13) 13
interleukin 6 (13) 13
research (13) 13
therapy (13) 13
antibodies, monoclonal - pharmacokinetics (12) 12
castleman disease (12) 12
development and progression (12) 12
mice (12) 12
open-label (12) 12
treatment outcome (12) 12
article (11) 11
castleman's disease (11) 11
patients (11) 11
review (11) 11
signal transduction (11) 11
signal transduction - drug effects (11) 11
analysis (10) 10
c-reactive protein (10) 10
castleman disease - pathology (10) 10
cell biology (10) 10
clinical trials (10) 10
multicentric castleman's disease (10) 10
multiple myeloma - drug therapy (10) 10
antineoplastic agents - adverse effects (9) 9
apoptosis (9) 9
cell line, tumor (9) 9
elotuzumab (9) 9
lymph-node hyperplasia (9) 9
phase-i (9) 9
proteins (9) 9
survival (9) 9
tumors (9) 9
young adult (9) 9
angiofollicular lymph node hyperplasia (8) 8
antineoplastic agents - administration & dosage (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
cancer therapies (8) 8
daratumumab (8) 8
growth (8) 8
interleukin-6 - blood (8) 8
low-dose dexamethasone (8) 8
neoplasms - drug therapy (8) 8
prognosis (8) 8
targeted therapy (8) 8
antibodies, monoclonal - pharmacology (7) 7
antineoplastic agents - pharmacokinetics (7) 7
antineoplastic agents - pharmacology (7) 7
biochemistry & molecular biology (7) 7
bortezomib (7) 7
castleman disease - diagnosis (7) 7
cytokine (7) 7
dendritic cells (7) 7
drug therapy (7) 7
endothelial growth-factor (7) 7
gene expression (7) 7
growth-factor (7) 7
hematology, oncology and palliative medicine (7) 7
interleukin‐6 (7) 7
lymphomas (7) 7
medical prognosis (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BLOOD, ISSN 0006-4971, 04/2019, Volume 133, Issue 16, pp. 1697 - 1698
Journal Article
BLOOD, ISSN 0006-4971, 04/2019, Volume 133, Issue 16, pp. 1720 - 1728
Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder. The anti-interleukin 6 (IL-6) therapy siltuximab is not available... 
RESOLUTION | SILTUXIMAB | CLINICAL CHARACTERISTICS | ANTIBODY | OUTCOMES | HEMATOLOGY | FEATURES
Journal Article
by Koff JL and Lonial S
Biologics : Targets & Therapy, ISSN 1177-5491, 01/2016, Volume 2016, Issue Issue 1, pp. 9 - 15
Jean L Koff, Sagar Lonial Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA Abstract: Castleman disease (CD)... 
Castlemans disease | siltuximab
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2013, Volume 89, Issue 1, pp. 129 - 139
Journal Article
Cytokine and Growth Factor Reviews, ISSN 1359-6101, 2012, Volume 24, Issue 2, pp. 163 - 173
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue 22, pp. 2323 - 2330
Castleman disease (CD) describes a heterogeneous group of hematologic disorders that share characteristic lymph node histopathology. Patients of all ages... 
CLINICAL SPECTRUM | ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODY | DOUBLE-BLIND | SILTUXIMAB | OUTCOMES | INTERLEUKIN-6 | HEMATOLOGY | FEATURES | Review
Journal Article
Journal Article